Mineralys Therapeutics, Inc. MLYS Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s total assets?
- Mineralys Therapeutics, Inc. (MLYS) reported total assets of $652.86M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s total assets changed year-over-year?
- Mineralys Therapeutics, Inc.'s total assets increased by 83.9% year-over-year, from $354.94M to $652.86M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s total assets?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s total assets has grown at a 79.5% compound annual growth rate (CAGR), from $114.44M to $661.81M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.